126 related articles for article (PubMed ID: 8222478)
1. Intravenous ciprofloxacin disposition in obesity.
Allard S; Kinzig M; Boivin G; Sörgel F; LeBel M
Clin Pharmacol Ther; 1993 Oct; 54(4):368-73. PubMed ID: 8222478
[TBL] [Abstract][Full Text] [Related]
2. Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing.
Hollenstein UM; Brunner M; Schmid R; Müller M
Int J Obes Relat Metab Disord; 2001 Mar; 25(3):354-8. PubMed ID: 11319632
[TBL] [Abstract][Full Text] [Related]
3. Elimination of ciprofloxacin and three major metabolites and consequences of reduced renal function.
Bergan T; Thorsteinsson SB; Rohwedder R; Scholl H
Chemotherapy; 1989; 35(6):393-405. PubMed ID: 2612228
[TBL] [Abstract][Full Text] [Related]
4. The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin.
Frost RW; Lettieri JT; Krol G; Shamblen EC; Lasseter KC
Clin Pharmacol Ther; 1989 Jun; 45(6):608-16. PubMed ID: 2731404
[TBL] [Abstract][Full Text] [Related]
5. Disposition kinetics of ciprofloxacin in lactating goats.
el-Banna HA; Abo el-Sooud K
Dtsch Tierarztl Wochenschr; 1998 Jan; 105(1):35-8. PubMed ID: 9499632
[TBL] [Abstract][Full Text] [Related]
6. The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.
Bacracheva N; Scholl H; Gerova Z; Chervenakov P; Dobrev P; Vlahov V
Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):352-6. PubMed ID: 1937996
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
Mengozzi G; Intorre L; Bertini S; Soldani G
Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
[TBL] [Abstract][Full Text] [Related]
8. Dose-ranging pharmacokinetic study of ciprofloxacin after 200-, 300-, and 400-mg intravenous doses.
Nix DE; Spivey JM; Norman A; Schentag JJ
Ann Pharmacother; 1992 Jan; 26(1):8-10. PubMed ID: 1606348
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients.
Schaefer HG; Stass H; Wedgwood J; Hampel B; Fischer C; Kuhlmann J; Schaad UB
Antimicrob Agents Chemother; 1996 Jan; 40(1):29-34. PubMed ID: 8787874
[TBL] [Abstract][Full Text] [Related]
10. Preliminary study of the pharmacokinetics of oral amifloxacin in elderly subjects.
Stroshane RM; Silverman MH; Sauerschell R; Brown RR; Boddy AW; Cook JA
Antimicrob Agents Chemother; 1990 May; 34(5):751-4. PubMed ID: 2360815
[TBL] [Abstract][Full Text] [Related]
11. Disposition kinetics of danofloxacin and ciprofloxacin in broiler chickens.
el-Gendi AY; el-Banna HA; Abo Norag M; Gaber M
Dtsch Tierarztl Wochenschr; 2001 Oct; 108(10):429-34. PubMed ID: 11721591
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects.
Shah A; Lettieri J; Blum R; Millikin S; Sica D; Heller AH
J Antimicrob Chemother; 1996 Jul; 38(1):103-16. PubMed ID: 8858462
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
Anadón A; Martínez-Larrañaga MR; Díaz MJ; Fernández-Cruz ML; Martínez MA; Frejo MT; Martínez M; Iturbe J; Tafur M
Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
[TBL] [Abstract][Full Text] [Related]
14. Disposition of ciprofloxacin following intravenous administration in dogs.
Abadía AR; Aramayona JJ; Muñoz MJ; Pla Delfina JM; Saez MP; Bregante MA
J Vet Pharmacol Ther; 1994 Oct; 17(5):384-8. PubMed ID: 7853464
[TBL] [Abstract][Full Text] [Related]
15. Sex-related differences in the pharmacokinetics of oral ciprofloxacin.
Overholser BR; Kays MB; Forrest A; Sowinski KM
J Clin Pharmacol; 2004 Sep; 44(9):1012-22. PubMed ID: 15317829
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of difloxacin in goats.
Atef M; el-Banna HA; Abd El-Aty AM; Goudah A
Dtsch Tierarztl Wochenschr; 2002 Jul; 109(7):320-3. PubMed ID: 12161971
[TBL] [Abstract][Full Text] [Related]
17. Transintestinal elimination of ciprofloxacin.
Rohwedder R; Bergan T; Thorsteinsson SB; Scholl H
Chemotherapy; 1990; 36(2):77-84. PubMed ID: 2311444
[TBL] [Abstract][Full Text] [Related]
18. Cimetidine disposition in obesity.
Abernethy DR; Greenblatt DJ; Matlis R; Gugler R
Am J Gastroenterol; 1984 Feb; 79(2):91-4. PubMed ID: 6364798
[TBL] [Abstract][Full Text] [Related]
19. Digoxin disposition in obesity: clinical pharmacokinetic investigation.
Abernethy DR; Greenblatt DJ; Smith TW
Am Heart J; 1981 Oct; 102(4):740-4. PubMed ID: 7282520
[TBL] [Abstract][Full Text] [Related]
20. Ibuprofen disposition in obese individuals.
Abernethy DR; Greenblatt DJ
Arthritis Rheum; 1985 Oct; 28(10):1117-21. PubMed ID: 4052122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
